Company / Cost of Revenue
Silo Pharma, Inc. Cost of Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$5.8K
FY2025
5-year range
$5.8K / $27.4K
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$5,838 in FY2025 with a 5-year CAGR of -26.6%.
Remained stable around $5,838 over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -26.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -26.6%, indicating a declining trend.
- In FY2025, cost of revenue increased 0.0% year-over-year.
- Peak cost of revenue was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.8K | +0.0% |
| FY2024 | $5.8K | +0.0% |
| FY2023 | $5.8K | -78.7% |
| FY2020 | $27.4K | +0.0% |
| FY2019 | $27.4K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026